Aurobindo Pharma Limited — Naproxen Exporter Profile
Indian Pharmaceutical Exporter · #9 for Naproxen · $3.8M export value · DGFT Verified
Aurobindo Pharma Limited is the #9 Indian exporter of Naproxen with $3.8M in export value and 183 verified shipments. Aurobindo Pharma Limited holds a 2.8% market share in Naproxen exports across 5 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Naproxen Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Naproxen?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $5.8M | 516 | 84.7% |
| UNITED KINGDOM | $461.7K | 13 | 6.8% |
| UNITED STATES OF AMERICA | $352.4K | 8 | 5.2% |
| NETHERLANDS | $214.4K | 17 | 3.1% |
| PORTUGAL | $16.5K | 1 | 0.2% |
Aurobindo Pharma Limited exports Naproxen to 5 countries. The largest destination is MALTA accounting for 84.7% of Aurobindo Pharma Limited's Naproxen shipments, followed by UNITED KINGDOM (6.8%) and UNITED STATES OF AMERICA (5.2%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Naproxen from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $2.9M | 291 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $1.0M | 74 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $620.3K | 52 |
| APL SWIFT SERVICES (MALTA) LIMITED | MALTA | $478.6K | 34 |
| MILPHARM LIMITED | UNITED KINGDOM | $376.9K | 9 |
| APL SWIFT SERVICES (MALTA) LTD | MALTA | $335.6K | 18 |
| XXL SXXFT XXRVIXXS (XXLTAXXLIMXXED | MALTA | $279.6K | 11 |
| XXROBXXDO XXARMXXUSAXXNC | UNITED STATES OF AMERICA | $252.4K | 6 |
| APL SWIFT SERVICES (MALTA) LIMITED, | MALTA | $130.4K | 32 |
| XXROHXXLTHXXLC | UNITED STATES OF AMERICA | $100.0K | 2 |
Aurobindo Pharma Limited supplies Naproxen to 19 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APL SWIFT SERVICES MALTA LIMITED (MALTA) and APL SWIFT SERVICES MALTA LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Naproxen Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $77.8M worth of Naproxen through 3,414 shipments from 192 suppliers to 76 countries, serving 366 buyers globally. Aurobindo Pharma Limited contributes $3.8M to this total, accounting for 2.8% of India's Naproxen exports. Aurobindo Pharma Limited ships Naproxen to 5 countries through 19 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Naproxen Exports?
Aurobindo Pharma Limited's average Naproxen shipment value is $20.7K per consignment, based on 183 shipments totaling $3.8M. The largest destination is MALTA (84.7% of Aurobindo Pharma Limited's Naproxen exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Naproxen Exporters?
Aurobindo Pharma Limited ranks #9 among 192 Indian Naproxen exporters with a 2.8% market share. The top 3 exporters are GLENMARK PHARMACEUTICALS LIMITED ($14.1M), UNICHEM LABORATORIES LIMITED ($13.8M), GRANULES INDIA LIMITED ($8.5M). Aurobindo Pharma Limited processed 183 shipments to 5 destination countries.
What Naproxen Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NAPROXEN 500MG TABLETSNaproxen Aurobindo 500 mg tabletten30'S | $245.1K | 8 |
| NAPROXEN 500MG TABLETS(APO-NAPRO, 500 MG, TABLETKI)30'S | $229.2K | 19 |
| NAPROXEN 500MG TABLETS(Naproxen Aurobind | $219.2K | 11 |
| NAPROXEN 250MG TABLETS(Apo-Napro, 250 mg | $214.4K | 12 |
| NAPROXEN 500MG TABLETSApo-Napro 500 mg tabletki30'S | $213.2K | 6 |
| NAPROXEN 500MG TABLETS, (Naproxen Aurobi | $192.2K | 6 |
| NAPROXEN 500MG TABLETS(Apo-Napro, 500 mg | $186.9K | 8 |
| NAPROXEN 500MG TABLETS (NAPROXEN TABLETSBP 500 MG) 2X14'S | $179.0K | 4 |
| NAPROXEN 500MG TABLETS(Naproxeno Generis | $168.9K | 11 |
| NAPROXEN 500MG TABLETS(APO-NAPRO 500MG T | $163.0K | 7 |
Aurobindo Pharma Limited exports 271 distinct Naproxen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NAPROXEN 500MG TABLETSNaproxen Aurobindo 500 mg tabletten30' with 8 shipments worth $245.1K.
Regulatory Requirements: Exporting Naproxen to Key Markets
What Aurobindo Pharma Limited must comply with to export Naproxen to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Naproxen Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MARKSANS PHARMA LIMITED | $5.1M | 149 | 2 | $34.3K |
| 6 | DR.REDDY'S LABORATORIES LTD | $4.0M | 81 | 5 | $50.0K |
| 9 | AUROBINDO PHARMA LIMITED ★ | $3.8M | 183 | 5 | $20.7K |
| 10 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $3.6M | 127 | 4 | $28.4K |
| 11 | APOTEX RESEARCH PRIVATE LIMITED | $3.5M | 86 | 1 | $40.9K |
Aurobindo Pharma Limited ranks #9 among 192 Indian Naproxen exporters. Average shipment value of $20.7K compared to the market average of $405.2K. The closest competitors by value are MARKSANS PHARMA LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Naproxen Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 429 | 12.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 245 | 7.2% |
| SAHAR AIR | 236 | 6.9% |
| DELHI AIR CARGO ACC (INDEL4) | 211 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.6% |
| HYDERABAD ICD | 145 | 4.2% |
| VIZAG SEA | 140 | 4.1% |
| BANGALORE AIR | 128 | 3.7% |
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Naproxen, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Naproxen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 555 individual customs records matching Aurobindo Pharma Limited exporting Naproxen, covering 271 formulations to 5 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Naproxen Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Naproxen exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Naproxen Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Naproxen. For current shipment-level data, contact TransData Nexus.